Showing results (1351-1360 of 1,385) with videos related to

Sort By:
Pageof 139
The Lancet. Digital Health|August 21, 2021
Development and validation of deep learning classifiers to detect Epstein-Barr virus and microsatellite instability status in gastric cancer: a retrospective multicentre cohort studyHannah Sophie Muti, Lara Rosaline Heij, Gisela Keller, et al.
Advances in Nutrition (Bethesda, Md.)|June 1, 2025
Contribution of Maternal Adherence to the Effect of Multiple Micronutrient Supplementation During Pregnancy: A Systematic Review and Individual Participant Data Meta-analysisEmily R Smith, Filomena Gomes, Seth Adu-Afarwuah, et al.
Cell|May 20, 2021
B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoVJohannes F Scheid, Christopher O Barnes, Basak Eraslan, et al.
Nature Medicine|January 17, 2017
Antibody 10-1074 suppresses viremia in HIV-1-infected individualsMarina Caskey, Till Schoofs, Henning Gruell, et al.
Cancer Cell|June 11, 2026
Spatial biomarker discovery via interpretable semantic learning in histopathologyJunhao Liang, Xiaofeng Jiang, Nic Gabriel Reitsam, et al.
Mbio|April 23, 2015
Neutralization properties of simian immunodeficiency viruses infecting chimpanzees and gorillasHannah J Barbian, Julie M Decker, Frederic Bibollet-Ruche, et al.
Nature Immunology|February 3, 2026
Identification of a potent V3 glycan site broadly neutralizing antibody targeting an N332<sub>gp120</sub> glycan-independent epitopeLutz Gieselmann, Andrew T DeLaitsch, Malena Rohde, et al.
Nature|September 28, 2018
Combination therapy with anti-HIV-1 antibodies maintains viral suppressionPilar Mendoza, Henning Gruell, Lilian Nogueira, et al.
Biorxiv : the Preprint Server for Biology|September 18, 2025
Identification of a broad and potent V3 glycan site bNAb targeting an N332<sub>gp120</sub> glycan-independent epitopeLutz Gieselmann, Andrew T DeLaitsch, Malena Rohde, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 5, 2026
The density of tumour infiltrating lymphocytes in oesophago-gastric cancer varies with disease stage, geographical region and treatment: a post hoc analysis of nine phase III clinical trialsGeorgina A Keogh, Nina Šefčovičová, Tomio Arai, et al.
Pageof 139